Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 30, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 30, 2026 Medical Data Vision Co., Ltd. [3902.T] TOKYO, Jan 30 (Kyodo) - Medical Data Vision Co., Ltd. (Code No.: 3902, Prime Market), announced today that its board of directors has resolved to set the record date for convening an extraordinary shareholders' meeting scheduled for late March 2026. The company's president and CEO, Hiroshi Iwasaki, stated that the decision was made to ensure clarity on who will be eligible to exercise voting rights at the upc